Keyphrases
Anthracycline Antibiotics
20%
Bioactive Compounds
20%
Broad-spectrum Activity
20%
Cancer Chemotherapeutics
20%
Chemotherapy Drugs
20%
Daunorubicin
20%
DNA Biosensor
20%
DNA Damage
100%
DNA Damage Response
20%
DNA Intercalation
20%
DNA Sensing
20%
Doxorubicin
60%
Ebola Virus
100%
Ebola Virus Proteins
20%
High-throughput Screening Assays
20%
Immune Antagonists
20%
Immune Escape
20%
Innate Immune Evasion
20%
Innate Immune Response
20%
Interferon Antagonist
40%
Interferon Induction
60%
Interferon Response
100%
Interferon-α (IFN-α)
40%
Interferon-β (IFN-β)
20%
Negative-sense RNA Virus
20%
Novel Assay
20%
Novel Therapeutics
20%
Public Health Risk
20%
Replication in Vitro
20%
RIG-I-like Receptors
20%
RNA Virus
60%
RNA Virus Replication
20%
Signaling Molecules
20%
Signaling Pathway
20%
Small Molecules
20%
Stimulator of Interferon Genes (STING)
20%
STING Pathway
40%
Therapeutic Approaches
20%
Therapeutic Intervention
20%
Topoisomerase II
20%
Topoisomerase Inhibitors
100%
Viral
20%
Viral Immune Evasion
100%
Virus Pathogenesis
20%
Virus Replication
40%
VP35
40%
Vulnerability
20%
Medicine and Dentistry
Anthracycline Antibiotic Agent
16%
Antiinfective Agent
33%
ATM Protein
16%
Beta Interferon
16%
DNA Damage
100%
DNA Damage Response
16%
DNA Topoisomerase (ATP Hydrolysing)
16%
Doxorubicin
50%
Ebolavirus
100%
Gyrase Inhibitor
100%
High Throughput Screening
16%
Immune Evasion
100%
In Vitro
16%
Infection
16%
Intercalating Agent
16%
Interferon
100%
Interferon Alfa
16%
Interferon Induction
50%
Liposomal Daunorubicin
16%
Malignant Neoplasm
16%
Negative-Strand RNA Virus
16%
Public Health
16%
Receptor
16%
Signal Transduction
33%
Signaling Protein
16%
Viral Protein
16%
Virus Pathogenesis
16%
Virus Replication
50%
Virus RNA
66%
Immunology and Microbiology
Beta Interferon
16%
DNA Damage
100%
DNA Damage Response
16%
Ebola Virus
100%
High Throughput Screening
16%
Immune Evasion
100%
interferon
100%
Interferon Alfa
16%
Interferon Induction
50%
Negative-Strand RNA Virus
16%
RIG-I-like Receptor
16%
RNA Virus
66%
Signal Transduction
33%
Viral Protein
16%
Viral Replication
50%
Pharmacology, Toxicology and Pharmaceutical Science
Alpha Interferon
11%
Anthracycline Antibiotic Agent
11%
Antiinfective Agent
22%
ATM Protein
11%
Beta Interferon
11%
Chemotherapy
11%
Daunorubicin
11%
DNA Topoisomerase (ATP Hydrolysing)
11%
Doxorubicin
33%
Ebola Virus
100%
Gyrase Inhibitor
100%
High-Throughput Screening
11%
Infection
11%
Intercalating Agent
11%
Interferon
100%
Malignant Neoplasm
11%
Negative-Strand RNA Virus
11%
Receptor
11%
Viral Protein
11%
Virus RNA
44%